Pandemic H1N1 Influenza Vaccine Quick Reference Guide



QUICK REFERENCE GUIDE FOR SCHOOL-BASED HPV IMMUNIZATIONS

Manitoba Eligibility Criteria for Publicly Funded Vaccines: As of March 31, 2014 all females in Grade 6, and females who missed the vaccine in grade 6 who were born on or after January 1’st 1997 are eligible to receive the publically funded HPV series. Females with increased risk of HPV infection who started the 3 dose vaccine series before March 31st, 2014 will be eligible to finish the series free of charge.

|Trade Name/ Manufacturer Description |Contents |Supplied |

|Gardasil® |Active ingredients: |Gardasil® supplied in single dose |

|Merck Canada |Prepared from the highly purified virus-like particles (VLPs) of the recombinant major capsid (L1) protein of HPV |glass vials |

|Quadrivalent Human Papillomavirus (Types 6, 11, 16, |Types 6, 11, 16, and 18. The L1 proteins are | |

|18) Recombinant Vaccine |produced by separate fermentations in recombinant Saccharomyces cerevisiae (yeast) and self-assembled into VLPs. The |Gardasil® is a white, cloudy |

| |vaccine contains yeast protein. |liquid. |

| |Inactive Ingredients: | |

| |Adjuvant: | |

| |aluminum (as amorphous aluminum hydroxyphosphate sulfate [AAHS]) | |

| |Other ingredients: | |

| |sodium chloride, L-histidine, polysorbate 80, sodium borate, water for injection. This product is latex free; no | |

| |preservatives or antibiotics. | |

Store refrigerated at 2°C to 8°C. Do not freeze. Protect from light. Shake well before use, after thorough agitation.

|Age |Dose / Schedule |Route |

| | |Needle Gauge / Length |

|Gardasil vaccine is approved for use in females ages |0.5 mL |IM (deltoid) |

|9- 45 years of age; and men 9 – 26 yrs. |Recommended schedule: | |

| |Preferred schedule is 0, 2 and 6 months1 |1- 1 ½ ” |

| | |22-25 G   |

1The preferred schedule is 0, 2, & 6 months. The minimum interval between the first and second dose is 1 month. The second and third doses should be separated by an interval of at least 12 weeks. (Canadian Immunization Guide Evergreen Edition at:

Source: Product Monograph Merck Canada May 15, 2013 at:

& MHHL Document “Human Papilloma Virus Information for Health Professionals” January 2013 at:

Canadian Immunization Guide Evergreen Ed. @

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download